Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival
Open Access
- 17 August 2010
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 11 (1) , 16
Abstract
Infections in hemodialysis (HD) patients lead to high morbidity and mortality rates and are associated with early cardiovascular mortality, possibly related to chronic inflammation. Intravenous (IV) iron is widely administered to HD patients and has been associated with increased oxidative stress and dysfunctional cellular immunity. The purpose of this study was to examine the effect of three commercially available IV iron preparations on intracellular reactive oxygen species generation and lymphocyte subpopulation survival.Keywords
This publication has 20 references indexed in Scilit:
- Decreased CD3+CD16+ natural killer‐like T‐cell percentage and zeta‐chain expression accompany chronic inflammation in haemodialysis patientsNephrology, 2009
- Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapyInternational Journal Of Clinical Practice, 2009
- Vascular Access–Related Infections: Definitions, Incidence Rates, and Risk FactorsAmerican Journal of Kidney Diseases, 2008
- Aspects of Immune Dysfunction in End-stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2008
- Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patientsNephrology Dialysis Transplantation, 2007
- Parenteral Iron CompoundsClinical Journal of the American Society of Nephrology, 2006
- Parenteral iron nephrotoxicity: Potential mechanisms and consequences1Kidney International, 2004
- Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patientsKidney International, 2004
- High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacityKidney International, 2003
- Impact of iron dextran on polymorphonuclear cell function among hemodialysis patientsClinical Nephrology, 2002